AMRI invites you to take a virtual tour of the AMRI Syracuse Research Center whose capabilities are aimed at rapid scale up and production of Intermediates, GMP raw materials and NCSS (Tox) material and phase-1 process development. The site’s kilo laboratory enhances AMRI’s existing R&D capabilities and technologies, and improves flexibility and speed during the transition between process development and scale-up of AMRI’s customers’ projects.
AMRI knows how to effectively use personnel and equipment to maximize productivity and reduce timelines, as well as avoid the pitfalls and the perils of scaling up too early. There is a need for process development that is ‘fit for purpose’ that delivers quality goods, suitable for use in preclinical trials or large-scale manufacturing.
But the question is can you really afford to ignore the benefits of this knowledge?
Director of AMRI’s Chemical Development, Charlie Montgomery will also give a webinar presentation on Wednesday. 30th October at 3PM London/11AM New York